B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo

被引:0
|
作者
Constant, SL [1 ]
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
来源
JOURNAL OF IMMUNOLOGY | 1999年 / 162卷 / 10期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The contribution of B lymphocytes as APCs for CD4(+) T cell priming remains controversial, based on findings that B cells cannot provide the requisite ligating and costimulatory signals for naive T cells to be activated. In the current study, we have examined Ag-specific T:B cell collaboration under circumstances in which B cells take up Ag through Ig receptors in vivo, This results in their activation and an ability to effectively stimulate naive CD4+ T cells both in vitro and in vivo. The aim of this work was to establish some of the key molecular interactions, as,veil as kinetics, between Ag-specific T and B cells that enable this priming to take plate, Our approach was to amplify the starting pools of both Ag-specific T and B cell populations in vivo to track directly the events during initial T:B cell collaborations, We show that the induction of optimal levels of T cell priming to a protein Ag requires the involvement of Ag-specific B cells. The interaction that results between Ag-specific T and B cells prevents the down-modulation of B7 costimulatory molecules usually observed in the absence of appropriate T cells. Moreover, this prevention in down-modulation is independent of CD40:CD40 ligand contact. Finally, we present data suggesting that once Ag-specific T and B cells interact, there is a rapid (1-2-h) down-regulation of antigenic complexes on the surface of the B lymphocytes, possibly to prevent them from engaging other T cells in the vicinity and therefore focus the initial interaction.
引用
收藏
页码:5695 / 5703
页数:9
相关论文
共 50 条
  • [11] THE SELECTIVE ANTIGEN-PRESENTING CELL CAPACITY OF ACTIVATED LYMPHOCYTES-B IN HLA-II-RESTRICTED RESPONSES OF CD4+ LYMPHOCYTES-T
    KRAAN, TTMV
    STIEKEMA, FEM
    TEUNISSEN, MBM
    BOS, JD
    KAPSENBERG, L
    IMMUNOLOGY, 1989, 68 (02) : 147 - 153
  • [12] Naive CD4+ T cell activation by antigen-presenting airway eosinophils.
    Wang, H
    Weller, PF
    CLINICAL IMMUNOLOGY, 2005, 115 : S46 - S46
  • [13] Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses
    Caserta, Stefano
    Alessi, Patrizia
    Guarnerio, Jlenia
    Basso, Veronica
    Mondino, Anna
    CANCER RESEARCH, 2008, 68 (08) : 3010 - 3018
  • [14] The role of B lymphocytes as antigen-presenting cells
    Chen, Xinjian
    Jensen, Peter E.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2008, 56 (02) : 77 - 83
  • [15] The role of B lymphocytes as antigen-presenting cells
    Xinjian Chen
    Peter E. Jensen
    Archivum Immunologiae et Therapiae Experimentalis, 2008, 56 : 77 - 83
  • [16] RESPONSE OF NAIVE ANTIGEN-SPECIFIC CD4+ T-CELLS INVITRO - CHARACTERISTICS AND ANTIGEN-PRESENTING CELL REQUIREMENTS
    CROFT, M
    DUNCAN, DD
    SWAIN, SL
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05): : 1431 - 1437
  • [17] B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner
    Rodríguez-Pinto, D
    Moreno, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) : 1097 - 1105
  • [18] Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells
    Ronchetti, A
    Iezzi, G
    Crosti, MC
    Garancini, MP
    Protti, MP
    Bellone, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (02) : 247 - 251
  • [19] Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro:: Implications in designing antigen-presenting cell-based tumor vaccines
    Chakraborty, NG
    Li, L
    Sporn, JR
    Kurtzman, SH
    Ergin, MT
    Mukherji, B
    JOURNAL OF IMMUNOLOGY, 1999, 162 (09): : 5576 - 5583
  • [20] HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells
    Maus, MV
    Riley, JL
    Kwok, WW
    Nepom, GT
    June, CH
    CLINICAL IMMUNOLOGY, 2003, 106 (01) : 16 - 22